Cerebral hypoperfusion in familiar amyloid polyneuropathy

Cerebral hypoperfusion in familiar amyloid polyneuropathy - FAP-PET

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31535

Enrollment

Registered

2008-12-01

Start date

2008-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

systemisch amyloïdose familiar amyloid polyneuropathy Systemic amyloidosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with familiar amyloid polyneuropathy.

Exclusion criteria

Exclusion criteria: - prior stroke, contusion or other neurological or psychiatric condition which more probable to cause cognitive deficits - prior exposure to radiation in the setting of scientific research - pregnancy - age

Design outcomes

Primary

Measure	Time frame
Cerebral perfusion and metabolism measured with water-PET en FDG-PET.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results